Transpharmation Ltd.
Denvor Oorloff is a seasoned professional in business development with extensive experience in the life sciences sector. Currently serving as a Senior Business Development Manager at Transpharmation Ltd. since September 2020, Denvor plays a crucial role in supporting global neuroscience projects focused on CNS disorders. Previous positions include Commercial Manager at Bio Market Insights and Front Line Genomics, and Partnerships Director at Hanson Wade, where expertise in connecting industry players has been a hallmark. Earlier career experiences include territory sales management at Brooks Life Science Systems and healthcare scientist roles at Public Health England, emphasizing laboratory operations and molecular diagnostics. Denvor holds a Master of Science in Haematology from the University of Westminster and a Bachelor of Science in Biomedical Sciences from Brunel University London.
This person is not in any teams
Transpharmation Ltd.
Transpharmation is a contract research organisation led by scientists. As the largest boutique Neuroscience-specialised small and large animal CRO, we can connect drug developers with world-leading technology platforms. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. Our clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout our preclinical services. Success is measured by results and driven by a desire to make a difference. Our breadth of neuroscience expertise means clients are able to benchmark their compounds against clinical gold standards in well validated behavioural and molecular assays. Whether you are interested in pain models, sleep models or anything in between, please don’t hesitate to contact us. We are committed to on-time data delivery and flexibility in deal structuring for your project. As such we will work alongside you in collaborative research, via contract work or in a full-time capacity, wherever you are around the globe. NEW! Transpharmation and InterVivo Solutions have united to form the largest boutique Neuroscience-specialised small and large animal CRO. Transpharmation’s Facilities Management Company, Agenda Life Sciences, are one of only 14 establishments to hold the globally recognised AAALAC accreditation assuring clients of scientific validity and reliable, robust scientific outcomes.